akash.verma@cenmed.com
(732) 447-1115-
SML0611-5MGBiochem/physiol Actions ML213 is a selective opener of the potassium channels KCNQ2 and KCNQ4, with EC 50 values of 230 and 510 nM, respectively. Features and Benefits This compound is featured on the Potassium Channels page of the Handbook -
SML0661-25MGApplication ML216 has been used in cell proliferation assays. Biochem/physiol Actions ML216 is a 4- F -phenyl analog. -
SML0661-5MGApplication ML216 has been used in cell proliferation assays. Biochem/physiol Actions ML216 is a 4- F -phenyl analog. -
SML0815-25MGBiochem/physiol Actions YMU1 is a cell-permeable and nontoxic inhibitor of hTMPK (thymidylate kinase) that sensitizes tumor cells to doxorubicin in vitro and in vivo . Features and Benefits This compound is a featured product for Apoptosis -
SML0815-5MGBiochem/physiol Actions YMU1 is a cell-permeable and nontoxic inhibitor of hTMPK (thymidylate kinase) that sensitizes tumor cells to doxorubicin in vitro and in vivo . Features and Benefits This compound is a featured product for Apoptosis -
SML0872-25MGApplication MJN110 has been used as a monoacylglycerol lipase (MAGL) inhibitor to study its effect on aggressive grooming in rats. It has also been used to inhibit lipid droplet formation. -
SML0872-5MGApplication MJN110 has been used as a monoacylglycerol lipase (MAGL) inhibitor to study its effect on aggressive grooming in rats. It has also been used to inhibit lipid droplet formation. -
SML0926-5MGBiochem/physiol Actions ML314 is a biased agonist of the Neruotensin 1 (NTR1) receptor. ML314 induces recruitment of β:-arrestin to NTR1 with an EC 50 of 2 μ:M, but does not induce G-protein mediated Ca2+ mobilization. -
SML1004-25MGBiochem/physiol Actions ML211 is a very potent, dual inhbitor of lysophospholipase 1 (LYPLA1: IC 50 = 17 nM) and lysophospholipase 2 (LYPLA2: IC 50 = 30 nM). -
SML1004-5MGBiochem/physiol Actions ML211 is a very potent, dual inhbitor of lysophospholipase 1 (LYPLA1: IC 50 = 17 nM) and lysophospholipase 2 (LYPLA2: IC 50 = 30 nM). -
SML1694-25MGBiochem/physiol Actions TVB-3166 is a cell-permeable pyrrazole derivative that inhibits cellular palmitate synthesis (IC 50 <:100 nM) by fatty acid synthase (FASN) keto-reductase activity in a potent and reversible manner (IC 50 = 42 nM), -
SML1694-5MGBiochem/physiol Actions TVB-3166 is a cell-permeable pyrrazole derivative that inhibits cellular palmitate synthesis (IC 50 <:100 nM) by fatty acid synthase (FASN) keto-reductase activity in a potent and reversible manner (IC 50 = 42 nM),
